Tag Archives: shows

Array’s colorectal cancer data shows why Pfizer splashed out $11B for the biotech

One key incentive for Pfizer paying $ 11 billion for Array BioPharma was the positive early readouts from its triplet therapy for colorectal cancer. Now, the biotech has shown exactly how attractive that data are. A combination of Array’s BRAF inhibitor Braftovi, its MEK inhibitor Mektovi and the anti-EGFR drug Erbitux significantly extended lives of previously-treated patients… Read More »

University of Chicago Medicine study shows need to enhance patient rest, evaluate overnight interruptions for better patient experience – Healthcare Finance News

A new study published in the Journal of Hospital Medicine shows a hospital program designed to help patients get more rest for a better recovery process called SIESTA, or Sleep for Inpatients: Empowering Staff to Act, proved successful in cutting the number of times a patient was disturbed overnight and improved their experience. The program… Read More »

Healthy Food Makes You Happy: Research Shows A Healthy Diet Improves Your Mental Health – Forbes

Young woman buying fresh red peppers at supermarket. She’s picking peppers from the shelf.Getty Depression has many origins: genetic, triggered by a specific event or circumstance or lifestyle choices. But it is a disease of the brain, and researchers find that ensuring it receives the proper nutrients is a way to prevent and treat depression.… Read More »

Global trial shows CAR T therapy can lead to durable remissions in non-Hodgkin's lymphoma

In an update to a global clinical trial stretching from Philadelphia to four continents, the chimeric antigen receptor (CAR) T cell therapy Kymriah® (tisagenlecleucel, formerly CTL019) led to long-lasting remissions in patients with relapsed/refractory (r/r) diffuse large B-cell lymphoma (DLBCL). The most recent results from the trial will be presented today at the 60th American… Read More »

Australian experience shows high DAA uptake and rapid fall in rates of HCV viraemia among people who inject drugs

Providing hepatitis C virus (HCV) therapy with direct-acting antivirals (DAAs) to people who inject drugs can achieve rapid reductions in community prevalence of viraemia, according to Australian research published in the Journal of Hepatology. Uptake of HCV treatment increased from 10% to 41% after unrestricted access to DAAs was rolled out in March 2016, and the… Read More »